Tactiva Therapeutics
Jay Zhang, Ph.D., has large experience in Executive roles in Biopharma. Dr. Zhang is the co-founder & CEO of TriArm Therapeutics and is a Venture Partner of Panacea Venture. Dr. Zhang was also the General Manager and CEO of Dragonboat Biopharmaceutical Co., Ltd. He received a Ph.D. from the University of Utah and did his post-doctoral training at Stanford University.
This person is not in any offices
Tactiva Therapeutics
Tactiva Therapeutics is an immuno-oncology company specializing in potent cancer immunotherapy using a dual T cell receptor approach.